BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

University of North Carolina Granted $13.6M to Use Nanotechnology Against Cancer


9/27/2010 10:53:30 AM

Triangle Business Journal - by James Gallagher -- UNC cancer researchers have won a $13.6 million grant to work to use nanotechnology to improve the diagnosis and treatment of cancer.

The five-year grant from the National Cancer Institute is directed to UNC-Chapel Hill’s Carolina Center of Cancer Nanotechnology Excellence at the UNC Lineberger Comprehensive Cancer Center.

The work will be lead by Joel Tepper and Joseph DeSimone. DeSimone is well known for his work in nanotechnology and has spun of some of his past research into the pharmaceutical startup company Liquidia Technologies, which is collaborating on the project.

“Our efforts in nanomedicine show tremendous promise for improving the ways we detect and treat lung, brain, and breast cancer,” said DeSimone. “We have refined our ability to make nanoparticles with unprecedented control and precision, and continued work in this area will reveal better approaches to targeting cancer cells with potent therapies while leaving healthy cells intact.”

In total, the funding will support 52 faculty, postdoctoral trainees, students and staff members.




   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->